메뉴 건너뛰기




Volumn 47, Issue 6, 2007, Pages 727-737

Population pharmacokinetics of tigecycline in healthy volunteers

Author keywords

Pharmacokinetics; Phase I; Tigecycline

Indexed keywords

GLYCYLCYCLINE DERIVATIVE; ONDANSETRON; TIGECYCLINE;

EID: 34249087953     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270007300263     Document Type: Article
Times cited : (32)

References (18)
  • 1
    • 1642492861 scopus 로고    scopus 로고
    • The glycylcyclines, a comparative review with the tetracyclines
    • Zhanel GC, Homenuik K., Nichol K., et al. The glycylcyclines, a comparative review with the tetracyclines. Drugs. 2001 ; 64: 63-88.
    • (2001) Drugs , vol.64 , pp. 63-88
    • Zhanel, G.C.1    Homenuik, K.2    Nichol, K.3
  • 3
    • 0033926236 scopus 로고    scopus 로고
    • In vitro activities of the glycylcyline GAR-936 against gram-positive bacteria
    • Boucher HW, Wennersten DB, Eliopoulos GM In vitro activities of the glycylcyline GAR-936 against gram-positive bacteria. Antimicrob Agents Chemother. 2000 ; 44: 2225-2229.
    • (2000) Antimicrob Agents Chemother. , vol.44 , pp. 2225-2229
    • Boucher, H.W.1    Wennersten, D.B.2    Eliopoulos, G.M.3
  • 4
    • 0033954848 scopus 로고    scopus 로고
    • Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates. Diagn Microbial
    • Gales AG, Jones RN Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates. Diagn Microbial Infect Dis. 2000 ; 36: 19-36.
    • (2000) Infect Dis , vol.36 , pp. 19-36
    • Gales, A.G.1    Jones, R.N.2
  • 5
    • 0032918653 scopus 로고    scopus 로고
    • In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936)
    • Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother. 1999 ; 43: 738-744.
    • (1999) Antimicrob Agents Chemother. , vol.43 , pp. 738-744
    • Petersen, P.J.1    Jacobus, N.V.2    Weiss, W.J.3    Sum, P.E.4    Testa, R.T.5
  • 6
    • 28044443844 scopus 로고    scopus 로고
    • Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline
    • Rello J. Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline. J Chemother. 2005 ; 17 (suppl 1). 12-22.
    • (2005) J Chemother. , vol.17 , Issue.1 , pp. 12-22
    • Rello, J.1
  • 9
    • 0016684753 scopus 로고
    • Drug diffusion and bioavailability: Tetracycline metallic chelation
    • Chin TF, Lach JL Drug diffusion and bioavailability: tetracycline metallic chelation. Am J Hosp Pharm. 1975 ; 32: 625-629.
    • (1975) Am J Hosp Pharm. , vol.32 , pp. 625-629
    • Chin, T.F.1    Lach, J.L.2
  • 10
    • 0015922130 scopus 로고
    • Interaction of tetracylines with ribosomal subunits from Escherichia coli: A fluorometric investigation
    • Fey G., Reiss M., Kersten H. Interaction of tetracylines with ribosomal subunits from Escherichia coli: a fluorometric investigation. Biochemistry (Mosc). 1973 ; 12: 1160-1164.
    • (1973) Biochemistry (Mosc) , vol.12 , pp. 1160-1164
    • Fey, G.1    Reiss, M.2    Kersten, H.3
  • 11
    • 0025855089 scopus 로고
    • Fluxes and accumulation of tetracyclines by human blood cells
    • Gabler WL Fluxes and accumulation of tetracyclines by human blood cells. Res Commun Chem Pathol Pharmacol. 1991 ; 72: 39-51.
    • (1991) Res Commun Chem Pathol Pharmacol. , vol.72 , pp. 39-51
    • Gabler, W.L.1
  • 12
    • 34249069226 scopus 로고    scopus 로고
    • Metabolic disposition of [14C] tigecycline in human volunteers following intravenous infusion
    • Hoffman M., DeMaio W., Jordan RA, et al. Metabolic disposition of [14C] tigecycline in human volunteers following intravenous infusion. Presented at: Am Assoc Pharm Sci Annual Meeting ; Baltimore, MD ; November 8, 2004. Abstract P104.
    • Presented At: Am Assoc Pharm Sci Annual Meeting
    • Hoffman, M.1    Demaio, W.2    Jordan, R.A.3
  • 16
    • 0005112804 scopus 로고
    • Scientific commentary: Some suggestions for measuring predictive performance
    • Sheiner LB, Beal SL Scientific commentary: some suggestions for measuring predictive performance. J Pharmacokinet Biopharm. 1989 ; 9: 503-511.
    • (1989) J Pharmacokinet Biopharm , vol.9 , pp. 503-511
    • Sheiner, L.B.1    Beal, S.L.2
  • 17
    • 16244396084 scopus 로고    scopus 로고
    • Pharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrations
    • Sun HK, Ong CT, Umer A., et al. Pharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrations. Antimicrobial Agents Chemother. 2005 ; 49: 1629-1632.
    • (2005) Antimicrobial Agents Chemother. , vol.49 , pp. 1629-1632
    • Sun, H.K.1    Ong, C.T.2    Umer, A.3
  • 18
    • 19544371022 scopus 로고    scopus 로고
    • Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline
    • Conte JE, Golden JA, Kelly MG, Zurlinden E. Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline. Int J Antimicrob Agents. 2005 ; 25: 523-529.
    • (2005) Int J Antimicrob Agents , vol.25 , pp. 523-529
    • Conte, J.E.1    Golden, J.A.2    Kelly, M.G.3    Zurlinden, E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.